Chatham Rock Phosphate Limited
GELGF
$0.05
$0.009924.69%
| Weiss Ratings | GELGF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | GELGF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Good | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | GELGF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -1.67 | |||
| Price History | GELGF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 25.00% | |||
| 30-Day Total Return | 51.52% | |||
| 60-Day Total Return | -21.26% | |||
| 90-Day Total Return | -21.26% | |||
| Year to Date Total Return | 51.52% | |||
| 1-Year Total Return | -50.00% | |||
| 2-Year Total Return | -64.29% | |||
| 3-Year Total Return | -47.42% | |||
| 5-Year Total Return | -42.13% | |||
| 52-Week High % Change | -73.27% | |||
| 52-Week Low % Change | 206.11% | |||
| Price | GELGF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.15 | |||
| 52-Week Low Price | $0.01 | |||
| 52-Week Low Price (Date) | May 21, 2024 | |||
| 52-Week High Price (Date) | Oct 03, 2024 | |||
| Valuation | GELGF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 6.48M | |||
| Enterprise Value | 6.48M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.01 | |||
| Earnings Per Share Growth | -44.51% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | 0.83 | |||
| Enterprise Value/Revenue (TTM) | -9,929.63 | |||
| Price | $0.05 | |||
| Enterprise Value/EBITDA (TTM) | -6.25 | |||
| Enterprise Value/EBIT | -6.20 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | GELGF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 101.83M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | GELGF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 64 2 155 8185 | |||
| Address | -- | |||
| Website | www.rockphosphate.co.nz | |||
| Country | New Zealand | |||
| Year Founded | 2004 | |||
| Profitability | GELGF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 160,083.33% | |||
| Profit Margin | 148,000.00% | |||
| Management Effectiveness | GELGF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -11.52% | |||
| Return on Equity | -- | |||
| Income Statement | GELGF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -- | |||
| Total Revenue (TTM) | -600.00 | |||
| Revenue Per Share | $0.00 | |||
| Gross Profit (TTM) | -600.00 | |||
| EBITDA (TTM) | -952.60K | |||
| EBIT (TTM) | -960.50K | |||
| Net Income (TTM) | -888.00K | |||
| Net Income Avl. to Common (TTM) | -888.00K | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | 15.56% | |||
| EPS Diluted (TTM) | -0.01 | |||
| EPS Diluted Growth (Q YOY) | 29.73% | |||
| Balance Sheet | GELGF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 40.20K | |||
| Cash Per Share (Q) | $0.00 | |||
| Total Current Assets (Q) | 111.10K | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 5.08M | |||
| Current Ratio (Q) | 0.688 | |||
| Book Value Per Share (Q) | $0.05 | |||
| Total Assets (Q) | 5.25M | |||
| Total Current Liabilities (Q) | 161.40K | |||
| Total Debt (Q) | 34.10K | |||
| Total Liabilities (Q) | 171.90K | |||
| Total Common Equity (Q) | 5.08M | |||
| Cash Flow | GELGF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -115.20K | |||
| Cash from Financing (TTM) | 834.60K | |||
| Net Change in Cash (TTM) | -144.20K | |||
| Levered Free Cash Flow (TTM) | -626.50K | |||
| Cash from Operations (TTM) | -854.20K | |||
